Literature DB >> 28639531

Outcome of bone recycling using liquid nitrogen as bone reconstruction procedure in malignant and recurrent benign aggressive bone tumour of distal tibia: A report of four cases.

Eka Wiratnaya I Gede1, Arrisna Artha Ida Ayu2, Yudhi Setiawan I Gn2, Wien Aryana Ign1, Suyasa I Ketut3, Siki Kawiyana I Ketut4, Astawa Putu4.   

Abstract

Amputation still considered as primary choice of malignancy treatment in distal tibia. Bone recycling with liquid nitrogen for reconstruction following resection of malignant bone tumours offers many advantages. We presented four patients with osteosarcoma, Ewing sarcoma, adamantinoma and recurrent giant cell tumour over distal tibia. All of the patients underwent wide excision and bone recycling using liquid nitrogen as bone reconstruction. The mean functional Musculoskeletal Tumor Society (MSTS) score was 75% with no infection and local recurrent. The reconstruction provides good local control and functional outcome.

Entities:  

Keywords:  MSTS score; bone recycling; distal tibia; liquid nitrogen; malignant bone tumour; recurrent benign aggressive bone tumour

Mesh:

Substances:

Year:  2017        PMID: 28639531     DOI: 10.1177/2309499017713940

Source DB:  PubMed          Journal:  J Orthop Surg (Hong Kong)        ISSN: 1022-5536            Impact factor:   1.118


  3 in total

1.  Surgical options and reconstruction strategies for primary bone tumors of distal tibia: A systematic review of complications and functional outcome.

Authors:  Zhiqing Zhao; Taiqiang Yan; Wei Guo; Rongli Yang; Xiaodong Tang; Wei Wang
Journal:  J Bone Oncol       Date:  2018-12-04       Impact factor: 4.072

2.  Osteochondral allograft in the treatment of an extruded osteoarticular segment of the distal tibia: A case report.

Authors:  Sermsak Sukpanichyingyong; Jirasak Wongkaewpotong; Thananit Sangkomkamhang
Journal:  Trauma Case Rep       Date:  2022-02-22

3.  Outcomes of comprehensive treatment for primary osteosarcoma.

Authors:  Kazuhiko Hashimoto; Shunji Nishimura; Naohiro Oka; Masao Akagi
Journal:  SAGE Open Med       Date:  2020-05-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.